Disclosures for "The Clinical Spectrum of ANO3—Report of a New Family and Literature Review"
-
Dr. Percetti has nothing to disclose.
-
-
-
-
Dr. Ferrara has nothing to disclose.
-
-
Dr. RANGHETTI has nothing to disclose.
-
Dr. Ferrarese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Ferrarese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI.
-
Dr. Pezzoli has nothing to disclose.
-
Barbara Garavaglia has nothing to disclose.
-
Dr. Isaias has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Newronika. Dr. Isaias has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Isaias has stock in Newronika. Dr. Isaias has received research support from Fondazione Grigioni per il Morbo di Parkinson. The institution of Dr. Isaias has received research support from Fresco Parkinson Institute Italia Onlus. The institution of Dr. Isaias has received research support from Deutsche Forschungsgemeinschaft.
-
Dr. Sacilotto has nothing to disclose.